Design and Rationale of a Phase 2 Study of NeurOtoxin (Botulinum Toxin Type A) for the PreVention of Post-Operative Atrial Fibrillation – The NOVA Study

Authors: Jonathan P. Piccini, Anders Ahlsson, Paul Dorian, Marc A. Gillinov, Peter R. Kowey, Michael J. Mack, Carmelo A. Milano, Louis P. Perrault, Jonathan S. Steinberg, Nathan H. Waldron, Maxwell Adams, David B. Bharucha, Mitchell F. Brin, William Ferguson, Stefano Benussi - American Heart Journal 2021 cited by 22